Barely Significant
← all excerpts

Predicting immune responsiveness in ER-positive breast cancer for personalized therapy: a population-based study.

NPJ Precis Oncol · 2025 · PMC12287262 · PMID 40702082

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

borderline significantp = 0.050actually significant
The interaction between Immunescore and ProliferativeIndex was borderline significant in univariable analysis of the ER-positive subset (HR 0.68, CI 95% 0.46–1.0, p = 0.050) and significant in analysis of all tumors (HR 0.63, 95% CI: 0.47–0.84, p = 0.001), Supplementary Data S4 .

also in 3,746 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.